Cytorex Biosciences Inc. is a Florida-based Biopharma company with a patented technology (US Patent 7,1412,51) to treat cancer using an approach that has never been taken before: Inorganic Acids as actives.
Our lead compound is called Cytoreg® .
Cytoreg® is a combination of 4 inorganic acids and 2 organic acids in water, where The Fluoride (F- ion) of hydrofluoric acid is the active agent.
Cytoreg® will target and kill cancer cells without affecting normal cells, hence becoming a very effective and safe product to administer to human cancer patients.
The first indication for Cytoreg® is Glioblastoma Multiforme, a malingnant brain tumor with a very low cure rate. Cytoreg® can cross the blood brain barrier due to its very low molecular weight.
For More Information Please call us at 954-573-4006 or email us at cytorex@gmail.com
©2013.Cytorex International, Inc.